| Literature DB >> 36236150 |
Pilanee Vaithanomsat1, Nutthamon Boonlum1, Wantida Chaiyana2, Singkome Tima3, Songyot Anuchapreeda3, Chanaporn Trakunjae1, Waraporn Apiwatanapiwat1, Phornphimon Janchai1, Antika Boondaeng1, Hataitip Nimitkeatkai4, Amnat Jarerat5.
Abstract
Mushrooms are incredibly valuable macro fungi that are an important and integral part of the ecosystem. In addition to being used as cuisine, mushrooms have been used for medicinal purposes for many centuries. This research applied a process for recovering β-glucan (BG) from the antler-type fruiting body of Ganoderma lucidum as well as tested the biological activities related to cosmeceutical applications. The characterization of complex structure was performed by fourier-transform infrared (FTIR) and nuclear magnetic resonance (MNR) spectroscopies. The obtained extract contained 40.57% BG and 7.47% protein, with the detectable bioactivities of anti-tyrosinase and antioxidation. Consequently, it showed the activity that can be used to whiten the skin by reducing or inhibiting the process of skin pigmentation. The BG also showed moderate activities of anti-collagenase, anti-elastase, and anti-hyaluronidase. The test by the HET-CAM confirmed no skin irritation of the complex extract. Based on human peripheral blood mononuclear cell (PBMC) test, the BG had no significant inhibiting effect on cell viability. In addition, the obtained BG had functional properties higher than commercially available BG, especially oil-binding capacity. These findings provided new insights into the potential application of G. lucidum BG as a polymeric material in the cosmeceutical industries.Entities:
Keywords: Ganoderma lucidum; anti-tyrosinase activity; antioxidant; enzymatic recovery; mushroom; skin anti-ageing; β-glucan
Year: 2022 PMID: 36236150 PMCID: PMC9573635 DOI: 10.3390/polym14194202
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.967
Composition of commercially available G. lucidum BG and antler-type G. lucidum BG extract.
| BG Sources | BG | Carbohydrate | Fiber | Protein | Fat | Moisture | Ash |
|---|---|---|---|---|---|---|---|
|
| 48.69 ± 0.63 a | 54.61 b | 30.63 ± 0.22 a | 7.47 ± 0.10 b | 0.12 ± 0.04 b | 6.79 ± 0.28 a | 0.38 ± 0.13 a |
| Commercial BG | 40.57 ± 0.90 b | 59.29 a | 20.76 ± 0.02 b | 11.61 ± 0.12 a | 2.61 ± 0.01 a | 5.30 ± 0.01 b | 0.43 ± 0.21 a |
a,b Means ± SD in the column with different small superscript letters a and b indicate significant difference at p < 0.05 level (n = 3).
Figure 1FTIR spectra of commercial BG (a); and antler-type G. lucidum BG (b).
Figure 213C solid-state NMR spectra of commercial BG (a); and antler-type G. lucidum BG (b).
Antioxidant activities of antler-type G. lucidum BG.
| Antioxidant Activity | IC50 (mg/mL) | |
|---|---|---|
| L-Ascorbic Acid | ||
| DPPH• inhibition | 18.34 ± 5.77 * (R2 = 0.9584) | 0.05 ± 0.00 (R2 = 0.9584) |
| ABTS•+ inhibition | 0.07 ± 0.00 (R2 = 0.9947) | 0.06 ± 0.00 (R2 = 1.0000) |
| Ferric reducing power | 18.38 ± 1.68 * (R2 = 0.9584) | 0.03 ± 0.00 (R2 = 0.9985) |
IC50 = the concentration of G. lucidum BG inhibiting the activity of DPPH, ABTS and Ferric reducing power by 50%. Asterisk (*) denotes significant differences in means between G. lucidum BG and L-ascorbic acid determined using t-test (p < 0.001).
Anti-tyrosinase activity of antler-type G. lucidum BG.
| Anti-Tyrosinase Activity | Inhibition (%) | |
|---|---|---|
| Kojic Acid | ||
| Substrate: L-tyrosine | 97.66 ± 0.59 * | 99.11 ± 0.48 |
| 24.13 ± 1.34 ** | 89.80 ± 0.17 | |
The final concentration of G. lucidum BG and kojic acid in each tested system was 0.5 mg/mL. Asterisk (*) denotes significant differences in means between G. lucidum BG and kojic acid determined using t-test, * p <0.05 and ** p < 0.001.
Anti-ageing activity of antler-type G. lucidum BG.
| Anti-Ageing Activity | Inhibition (%) | ||
|---|---|---|---|
| EGCG | Oleanolic Acid | ||
| Anti-collagenase | 21.03 ± 2.64 * | 66.07 ± 1.26 | ND |
| Anti-elastase | 26.19 ± 3.37 * | 89.61 ± 3.04 | ND |
| Anti-hyaluronidase | 29.26 ± 4.48 * | ND | 81.35 ± 1.55 |
The final concentration of G. lucidum BG, EGCG, and oleanolic acid in each tested system was 0.5 mg/mL. Asterisk (*) denotes significant differences in means between G. lucidum BG and EGCG or oleanolic acid determined using t-test (p < 0.001). ND, not determined.
Effect of 1% w/v sodium lauryl sulfate solution (positive control), 0.9% w/v sodium chloride solution (negative control), and antler-type G. lucidum BG on hen’s egg chorioallantoic membrane before (0 min) and after exposure for 5 and 60 min.
| Samples | Before (0 min) | 5 min | 60 min | Irritation Score | |
|---|---|---|---|---|---|
| Negative | 0.9% |
|
|
| 0.00 |
| Positive | 1% |
|
|
| 15.07 ± 0.08 |
| Sample |
|
|
| 0.00 | |
| Vehicle | DI water |
|
|
| 0.00 |
Figure 3Effect of antler-type G. lucidum BG at various concentrations on cell viability of peripheral blood mononuclear cell (PBMC) from 5 healthy volunteers (#1–#5). Data were expressed as Mean ± SD values from 3 replications.
Water-holding capacity (WHC), water-binding capacity (WBC), swelling capacity (SC), and oil-holding capacity (OHC) of antler-type G. lucidum BG and commercial BG.
| BG Sources | WHC | WBC | SC | OHC |
|---|---|---|---|---|
|
| 1.96 ± 0.01 a | 0.17 ± 0.01 a | 41.34 ± 0.53 a | 8.15 ± 0.04 a |
| Commercial BG | 1.97 ± 0.01 a | 0.13 ± 0.01 b | 41.79 ± 0.27 a | 3.00 ± 0.32 b |
a,b Means ± SD in the column with different small superscript letters a, b indicate significant difference at p < 0.05 level (n = 3).